Barbara Kosacz is retiring as a Cooley partner to become the chief operating officer and general counsel for cancer therapeutics company Kronos Bio, Inc., which had been a firm client.
Kosacz was at Cooley for more than 25 years, and remains a senior counsel.
At Kronos, Kosacz will oversee internal operations and legal functions and be member of the executive leadership team, according to Norbert Bischofberger, the president and CEO of Kronos.
“Barbara is universally recognized as one of the top life sciences attorneys in the country, having worked with clients in structuring and negotiating some of the most transformational ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.